Page 8 - Alembic Caching News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alembic caching. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alembic Caching Today - Breaking & Trending Today

Alembic partner's anti blood cancer drug gets U.S. FDA nod

Updated:
Share Article
AAA
Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its novel, next generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood cancer.
The drug, which has been licensed to TG Therapeutics since 2012, has bagged the approval for the U.S. market. TG Therapeutics has the global license except for the Indian market which will be handled by Rhizen and Alembic.
The drug is for treatment is of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20 based regimen, and adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least three prior lines of systemic therapy. ....

Umbralisib Ukoniq , Swaroop Vakkalanka , Rhizen Pharma , Pranav Amin , Alembic Pharmaceuticals , Rhizen Pharmaceuticals , Alembic Pharmaceuticals Ltd , Alembic Pharma , பிரணவ் அமின் , அலெம்பிக் மருந்துகள் , அலெம்பிக் மருந்துகள் லிமிடெட் , அலெம்பிக் பார்மா ,

USFDA concludes inspection of Alembic Pharma's Karkhadi facility

With five observations Alembic Pharmaceuticals announced that United States Food and Drug Administration (USFDA)
has conducted an inspection at Alembic Pharmaceuticals New Injectable Facility
(F-3) located at Karkhadi from 29 January 2021 to 5 February 2021. This was a
scheduled inspection and at the end of the inspection, the USFDA issued a Form 483
with 5 observations.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue ....

United States , Alembic Pharmaceuticals , Drug Administration , United States Food , Alembic Pharmaceutical New Injectable Facility , Capital Market , Economy Of India , Alembic Group , Chirayu Amin , Alembic Pharmaceuticals New Injectable Facility , United States Food And Drug Administration , ஒன்றுபட்டது மாநிலங்களில் , அலெம்பிக் மருந்துகள் , ஒன்றுபட்டது மாநிலங்களில் உணவு , மூலதனம் சந்தை , பொருளாதாரம் ஆஃப் இந்தியா , அலெம்பிக் குழு , சிரயு அமின் ,

Alembic consolidated net profit rises 25.81% in the December 2020 quarter

Read more about Alembic consolidated net profit rises 25.81% in the December 2020 quarter on Business Standard. Sales rise 13.48% to Rs 14.48 crore ....

Particularsquarter Endeddec , Var Sales , Capital Market , வார் விற்பனை , மூலதனம் சந்தை ,

Adani Green share price: Stocks in the news: Adani Green, YES Bank, ICICI Lombard & Mindtree

YES Bank s board will meet on Friday to consider a proposal for further fundraising through various means. ....

Maruti Suzuki , Hatsun Agro , Infrastructure Developers , Adani Green Energy , Lt Finance Holdings , Adani Trading Services , Tata Communications , Singapore Exchange , Dalal Street , Alembic Pharma , Yes Bank , Maruti Suzuki India , Real Estate , Mart Intermesh , Indiamart Intermesh , Adani Green Share Price , Yes Bank Share Price , Pre Market , L Ampt Finance , மாருதி ஸஸூகீ , உள்கட்டமைப்பு டெவலப்பர்கள் , அதானி பச்சை ஆற்றல் , ல்ட் நிதி ஹோல்டிங்ஸ் , அதானி வர்த்தக சேவைகள் , டாடா தகவல்தொடர்புகள் , சிங்கப்பூர் பரிமாற்றம் ,

Alembic (₹106.3): Buy - The Hindu BusinessLine

Investors with a short term perspective can buy the stock of Alembic at current levels. The stock had encountered key resistance at around ₹120 in mid-September 2020 and was on a medium-term downtrend ....

Day Trading Guide , நாள் வர்த்தக வழிகாட்டி ,